Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Friday . The stock traded as high as $22.28 and last traded at $22.28, with a volume of 6414 shares traded. The stock had previously closed at $20.20.
Analyst Upgrades and Downgrades
Separately, JPMorgan Chase & Co. initiated coverage on shares of Ascentage Pharma Group International in a research report on Thursday. They set an “overweight” rating for the company.
Read Our Latest Stock Analysis on AAPG
Ascentage Pharma Group International Trading Up 7.2 %
About Ascentage Pharma Group International
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Further Reading
- Five stocks we like better than Ascentage Pharma Group International
- Airline Stocks – Top Airline Stocks to Buy Now
- MarketBeat Week in Review – 03/24 – 03/28
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Compound Interest and Why It Matters When Investing
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
